Live feed20:21:31·100dINSIDERFilingvia QuantisnowEVP, Chf Clinical Develop Ofcr Schneider Eugene converted options into 21,685 shares and sold $703,138 worth of shares (9,302 units at $75.59), increasing direct ownership by 24% to 63,890 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.IONS· Ionis Pharmaceuticals Inc.Health CareOriginal source
